China Resources Double-Crane Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000Q94
CNY
18.73
-1.04 (-5.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
2,541.71
2,662.80
3,078.71
2,663.38
2,619.15
3,052.52
3,144.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,541.71
2,662.80
3,078.71
2,663.38
2,619.15
3,052.52
3,144.85
Raw Material Cost
1,062.78
1,159.48
1,281.90
1,338.15
1,187.61
1,309.86
1,308.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.74
8.31
8.61
5.68
3.13
3.39
3.42
Selling and Distribution Expenses
968.32
849.68
1,068.47
991.73
880.46
1,059.80
1,113.12
Other Expenses
13.00
9.54
9.44
7.68
14.09
15.16
15.28
Total Expenditure (Excl Depreciation)
2,168.84
2,112.87
2,453.38
2,412.37
2,212.11
2,524.65
2,578.29
Operating Profit (PBDIT) excl Other Income
372.9
549.9
625.3
251
407
527.9
566.5999999999999
Other Income
28.04
46.90
55.26
101.91
80.50
145.41
50.91
Operating Profit (PBDIT)
373.26
744.60
833.33
451.23
615.93
888.44
582.55
Interest
7.74
8.31
8.61
5.68
3.13
3.39
3.42
Exceptional Items
1.27
2.02
0.00
-31.05
0.00
0.00
0.00
Gross Profit (PBDT)
1,478.93
1,503.32
1,796.81
1,325.24
1,431.55
1,742.67
1,835.93
Depreciation
0.00
193.54
193.54
193.39
193.39
184.76
0.00
Profit Before Tax
366.79
544.78
631.18
221.11
419.41
700.29
579.13
Tax
22.62
76.55
133.48
10.36
61.19
38.69
118.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
374.04
468.82
506.67
230.65
350.53
630.43
513.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
374.04
468.82
506.67
230.65
350.53
630.43
513.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.68
20.94
16.05
8.33
7.69
18.40
-11.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
375.73
489.76
522.73
238.98
358.23
648.83
502.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,318.55
11,041.03
10,919.69
10,407.86
10,193.71
9,934.14
10,407.86
Earnings per share (EPS)
0.36
0.45
0.49
0.22
0.34
0.61
0.49
Diluted Earnings per share
0.36
0.45
0.49
0.22
0.34
0.61
0.49
Operating Profit Margin (Excl OI)
13.58%
18.93%
18.99%
5.85%
13.06%
18.29%
16.9%
Gross Profit Margin
14.43%
27.73%
26.79%
15.56%
23.4%
28.99%
18.42%
PAT Margin
14.72%
17.61%
16.46%
8.66%
13.38%
20.65%
16.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is -2.96% vs 0.55% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 4.89% vs -7.30% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -35.52% vs -9.71% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 148.39% vs -11.43% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of China Resources Double-Crane Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,541.71
0
2,541.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,541.71
0
2,541.71
Raw Material Cost
1,062.78
0
1,062.78
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.74
0
7.74
Selling and Distribution Expenses
968.32
0
968.32
Other Expenses
13.00
0.00
13.00
Total Expenditure (Excl Depreciation)
2,168.84
0
2,168.84
Operating Profit (PBDIT) excl Other Income
372.87
0.00
372.87
Other Income
28.04
0
28.04
Operating Profit (PBDIT)
373.26
0
373.26
Interest
7.74
0
7.74
Exceptional Items
1.27
0
1.27
Gross Profit (PBDT)
1,478.93
0
1,478.93
Depreciation
0.00
0
0.00
Profit Before Tax
366.79
0
366.79
Tax
22.62
0
22.62
Provisions and contingencies
0
0
0.00
Profit After Tax
374.04
0
374.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
374.04
0
374.04
Share in Profit of Associates
0
0
0.00
Minority Interest
1.68
0
1.68
Other related items
0.00
0.00
0.00
Consolidated Net Profit
375.73
0
375.73
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,318.55
0
11,318.55
Earnings per share (EPS)
0.36
0
0.36
Diluted Earnings per share
0.36
0
0.36
Operating Profit Margin (Excl OI)
13.58%
0%
0.00
13.58%
Gross Profit Margin
14.43%
0%
0.00
14.43%
PAT Margin
14.72%
0%
0.00
14.72%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 254.17 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -4.55% vs -13.51% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -2.96% vs 0.55% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 37.57 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -23.30% vs -6.29% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 4.89% vs -7.30% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 34.52 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -50.52% vs -10.33% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -35.52% vs -9.71% in Sep 2024

Quarterly - Interest
Interest 0.77 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -7.23% vs -3.49% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 148.39% vs -11.43% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.58%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024